Recently the United States Supreme Court has rejected two bids by Bayer (the purchaser of Monsanto) to dismiss litigation that Round Up weed killer causes cancer.
Round Up is a glyphosate based herbicide manufactured by Monsato. Essentially it is a weed killer. Glyphosate is known as a probable human carcinogen that is linked to the development of Non Hodgkin’s Lymphoma (NHL).
The Supreme Court denied a petition by Bayer that had asked the Court to consider whether the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) preempts a state law failure to warn claim regarding warnings labels on Round Up weed killer.
In Hardeman v. Monsanto Company, the Plaintiff, Edwin Hardeman had won a verdict against Monsanto in the spring of 2019. A jury unanimously decided that Mr. Hardeman’s non-Hodgkin’s lymphoma was caused by Round Up weedkiller and that Monsanto had failed to warn of this danger. The 9th Circuit Court of Appeals affirmed this verdict and Bayer appealed the decision to the U.S. Supreme Court.
On June 21, 2022, the Supreme Court denied the petition without comment. Leaving the 9th Circuits decision in place. On June 27, 2022, the Supreme Court denied another appeal by Bayer regarding a Round Up verdict.
Jeffrey Glassman Injury Lawyers continue to pursue Round Up claims for individuals who have been diagnosed with Hodgkin’s Lymphoma (NHL). If you were diagnosed with non-Hodgkin’s lymphoma between the ages of 18-65 and used Round Up weedkiller for at least five (5) years, please contact Jeffrey Glassman Injury Lawyers to discuss your potential case.